Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock(KU Leuven), Bart Claes(KU Leuven), David Bernasconi(SIB Swiss Institute of Bioinformatics), Jef De Schutter(KU Leuven), Bart Biesmans(KU Leuven), George Fountzilas(Aristotle University of Thessaloniki), Konstantine T. Kalogeras(Aristotle University of Thessaloniki), Vassiliki Kotoula(Aristotle University of Thessaloniki), Demetris Papamichael, Pierre Laurent‐Puig(Délégation Paris 5), Frédérique Penault–Llorca(Centre Jean Perrin), Philippe Rougier(Hôpital Ambroise-Paré), Bruno Vincenzi(Università Campus Bio-Medico), Daniele Santini(Università Campus Bio-Medico), Giuseppe Tonini(Università Campus Bio-Medico), Federico Cappuzzo(Ospedale di Livorno), Milo Frattini, Francesca Molinari, Piercarlo Saletti(Ospedale San Giovanni Bellinzona), Sara De Dosso(Ospedale San Giovanni Bellinzona), Miriam Martini(University of Turin), Alberto Bardelli(University of Turin), Salvatore Siena(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Andrea Sartore‐Bianchi(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Josep Tabernero(Vall d'Hebron Hospital Universitari), Teresa Macarulla(Vall d'Hebron Hospital Universitari), Frédéric FIORE(Inserm), Alice Gangloff(Inserm), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Per Pfeiffer(University of Southern Denmark), Camilla Qvortrup(University of Southern Denmark), Tine Plato Hansen(Odense University Hospital), Eric Van Cutsem(KU Leuven), Hubert Piessevaux(Cliniques Universitaires Saint-Luc), Diether Lambrechts(KU Leuven), Mauro Delorenzi(SIB Swiss Institute of Bioinformatics), Sabine Tejpar(KU Leuven)
Cited by 2,136
Abstract
Related Papers
No related papers found
Powered by citation graph analysis